0001209191-14-072924.txt : 20141203
0001209191-14-072924.hdr.sgml : 20141203
20141203212422
ACCESSION NUMBER: 0001209191-14-072924
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141201
FILED AS OF DATE: 20141203
DATE AS OF CHANGE: 20141203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC
CENTRAL INDEX KEY: 0001008848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
BUSINESS PHONE: 914-347-4300
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COHEN RON
CENTRAL INDEX KEY: 0001272354
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50513
FILM NUMBER: 141264983
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-01
0
0001008848
ACORDA THERAPEUTICS INC
ACOR
0001272354
COHEN RON
420 SAW MILL RIVER ROAD
ARDSLEY
NY
10502
0
1
0
0
President and CEO
Common Stock
2014-12-01
4
M
0
51265
8.14
A
529794
D
Common Stock
2014-12-01
4
S
0
34394
35.5918
D
495400
D
Employee Stock Option (right to buy)
8.14
2014-12-01
4
M
0
51265
0.00
D
2015-01-01
Common Stock
51265
0
D
Exercise and sales pursuant to a 10b5-1 plan. Dr. Cohen exercised 51,265 stock options, all of which were due to expire 1/1/2015 unless exercised. Dr. Cohen sold 19,200 of the resultant shares, the proceeds of which are being used to fund the exercise of the options and the resulting tax liability. In addition, Dr. Cohen vested in 30,384 shares of restricted stock of which he sold 15,194 shares, the proceeds of which are being used to fund the resulting tax liability. A record of all of Dr. Cohen's holdings is available in Acorda's SEC filings. Dr. Cohen retains the majority of the equity he has been granted in the Company since founding Acorda in 1995.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $35.27 to $36.27 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The shares subject to these options vested in installments and were fully vested on 3/01/2009.
/s/ Ron Cohen
2014-12-03